By Dorothy Atkins ( April 7, 2022, 7:52 PM EDT) -- The German molecular diagnostics provider Qiagen hit Bio-Rad Laboratories Inc. with a lawsuit in Delaware federal court Wednesday, asking a judge to declare that its QIAcuity technology used to quickly test municipal sewer systems across the U.S. for COVID-19 outbreaks doesn't infringe six Bio-Rad diagnostics patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.